News
Qualcomm Monitoring Health of Japanese Seniors
July 28, 2010 5:37 am | by San Diego Business Journal | CommentsIn partnership with a Japanese corporation, Qualcomm Inc. said July 22 that it has embarked on an experiment to monitor the health of 300 elderly residents in rural Japan, including areas of snow-prone Hokkaido in the north.
Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH)
July 28, 2010 5:36 am | by Bio-Medicine.Org | CommentsNEW YORK , July 28 /- Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the signing of a cooperative research and development agreement (CRADA) with the National Institute...
EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS
July 28, 2010 2:35 am | by Bio-Medicine.Org | CommentsROCKLAND, Mass. , July 28 /- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany , announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple...
Morphine blocks tumor growth
July 27, 2010 10:32 pm | by EurekAlert | Comments(American Journal of Pathology) Current research suggests that taking morphine can block new blood vessel and tumor growth. The related report by Koodie et al, "Morphine suppresses tumor angiogenesis through a HIF1α/p38MAPK pathway," appears in the August 2010 issue of the American...
Speeding Up Diagnosis of Infectious Disease
July 27, 2010 8:35 pm | by Massachusetts Institute of Technology | CommentsA startup is developing sequencing-based tests that could detect infections within 24 hours.
NuVasive 2Q net income jumps on sales boost
July 27, 2010 2:45 pm | by The Associated Press | CommentsNuVasive Inc. said Tuesday that its second-quarter net income surged on a boost in sales of surgical systems. The medical device maker also raised its earnings guidance for the year.The company said it earned $6.7 million, or 17 cents per share, up from $2.8 million, or 7 cents per share,...
Reform of primary care could reduce diagnostic errors
July 27, 2010 12:33 pm | by Baylor College of Medicine | CommentsErrors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant,...
Fluxion Biosciences wins R & D 100 award for the IonFlux HT System
July 27, 2010 11:35 am | by I-Micronews | CommentsFluxion Biosciences, a leading provider of functional cell analysis systems for drug discovery and diagnostics, announced that it has won a 2010 R&D 100 Award for its IonFlux? HT System.
Kinetic Concepts 2Q net income falls on costs
July 27, 2010 10:45 am | by The Associated Press | CommentsMedical technology company Kinetic Concepts Inc. said Tuesday its second-quarter net income fell 8 percent because of administrative and other costs.Company shares slid fell $1.31, or 3.6 percent, to $35.36 in afternoon trading. The stock has traded between $30.23 and $53.01 over the last 52...
Carbon nanotubes at heart of new system to cool 'power electronics'
July 27, 2010 10:38 am | by I-Micronews | CommentsResearchers have shown that an advanced cooling technology being developed for high-power electronics in military and automotive systems is capable of handling roughly 10 times the heat generated by conventional computer chips.
Silicon photonics experts set up EU cluster
July 27, 2010 10:38 am | by I-Micronews | CommentsTen European consortia working on silicon photonics join forces to help transfer technology to electronics industry.
Antigenics advances herpes vaccine
July 27, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | CommentsAntigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine.
Minn.-based 3M settles Wis. air-pollution charges
July 27, 2010 9:45 am | by The Associated Press | CommentsWisconsin officials say 3M Co. has agreed to pay $150,000 to settle allegations of air-pollution violations at its Prairie du Chien (doo SHEEN') facility.The state attorney general's office said Tuesday the company had modified an air-pollution source without a required permit. The office also...
Safety Tips for Laboratorians: How Laboratorians Can Safely Calculate Workload for FDA-Approved Semi-Automated Gynecologic Cytology Screening Devices
July 27, 2010 9:36 am | by U.S. Food & Drug Administration | CommentsThe purpose of this communication is to clarify for laboratories how workload should be calculated when using currently FDA-approved semi-automated gynecologic cytology screening devices. This communication is intended for cytotechnologists, technical...
Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals
July 27, 2010 9:35 am | by Bio-Medicine.Org | CommentsNEW BRUNSWICK, N.J. , July 27 /- James M. Golubieski , president of Foundation Venture Capital Group, LLC, (FVCG) a New Jersey Health Foundation/Foundation of UMDNJ affiliate, announced today that it has sold its equity interest in Longevica Pharmaceuticals, Inc., to Rostock International...
